Description
Amexosyn-457 DT — Amoxycillin-Clavulanate Dispersible Tablets for Complete Pediatric Antibiotic Protection
Amexosyn-457 DT combines Amoxycillin 400 mg with Clavulanic Acid 57 mg in a dispersible tablet formulation, making it well suited to pediatric dosing where swallowing whole tablets isn’t practical. Amoxycillin is a broad-spectrum penicillin antibiotic effective against a wide range of bacterial infections, while Clavulanic Acid acts as a beta-lactamase inhibitor that protects Amoxycillin from bacterial resistance and enhances its overall efficacy. This combination is frequently prescribed for respiratory tract infections, ENT infections, tonsillitis, sinusitis, skin and soft tissue infections, and urinary tract infections in children, giving franchise partners a genuinely high-frequency molecule for their pediatric antibiotic range.
Dispersible Formulation Backed by Reliable Manufacturing
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company headquartered in Panchkula, Haryana with manufacturing carried out at our Baddi, Himachal Pradesh facility. Dispersible tablets for children require precise formulation to ensure quick, uniform dissolution and consistent taste with every dose and Amexosyn-457 DT is manufactured under strict quality control to maintain this reliability across batches. For a PCD pharma franchise company in India, offering a dependable pediatric antibiotic combination gives field partners a strong entry point with pediatricians and general physicians treating childhood infections.
Product Highlights for Franchise Partners
- Composition: Amoxycillin 400 mg + Clavulanic Acid 57 mg
- Dosage Form: Dispersible Tablets
- Indications: Respiratory tract infections, ENT infections, tonsillitis and sinusitis, skin and soft tissue infections, urinary tract infections
- Key Benefit: Complete protection against bacterial infections in children
- Suited For: Distributors and medical representatives expanding their pediatric antibiotic range
Franchise partners looking to add a dependable pediatric antibiotic combination to their portfolio can explore this and other formulations through our PCD pharma franchise division, with complete launch support.
Disclaimer: This is a prescription antibiotic for children and should be used strictly under the supervision of a registered medical practitioner.
